Innocan Pharma Corp. buy Heisinger
Start price
17.09.21
/
50%
€0.89
Target price
17.09.22
-
Performance (%)
-55.14%
End price
19.05.22
€0.40
Summary
This prediction ended on 19.05.22 with a price of €0.40. The BUY prediction by Heisinger for Innocan Pharma Corp. performed very badly with a performance of -55.14%. Heisinger has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Innocan Pharma Corp. | - | - | - |
iShares Core DAX® | 0.597% | 3.083% | 16.090% |
iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% |
iShares Nikkei 225® | 1.775% | -1.206% | 6.823% |
iShares S&P 500 | 0.990% | 3.500% | 24.956% |
Comments by Heisinger for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.